Literature DB >> 30578851

Platin chemotherapy hypersensitivity reactions: Expanding the scope of practice and improving care.

Amy S Levin1, Gita Bhattacharya2, Kimberly Blumenthal3, Carlos A Camargo4, Aleena Banerji2.   

Abstract

Entities:  

Year:  2018        PMID： 30578851      PMCID： PMC6511316          DOI： 10.1016/j.jaip.2018.12.010

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  9 in total

1.  Hypersensitivity reaction to cisplatin during chemoradiation therapy for gynecologic malignancy.

Authors:  Claude Koren; Rinat Yerushalmi; Alan Katz; Hana Malik; Aaron Sulkes; Eyal Fenig
Journal:  Am J Clin Oncol       Date:  2002-12       Impact factor: 2.339

2.  Risk-stratification protocol for carboplatin and oxaliplatin hypersensitivity: repeat skin testing to identify drug allergy.

Authors:  Alberta L Wang; Sarita U Patil; Aidan A Long; Aleena Banerji
Journal:  Ann Allergy Asthma Immunol       Date:  2015-08-19       Impact factor: 6.347

3.  Anaphylaxis after oxaliplatin allergy skin testing.

Authors:  J Martin-Lazaro; J L Firvida; P Berges-Gimeno
Journal:  J Investig Allergol Clin Immunol       Date:  2014       Impact factor: 4.333

4.  Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitization.

Authors:  E Alvarez-Cuesta; R Madrigal-Burgaleta; D Angel-Pereira; A Ureña-Tavera; M Zamora-Verduga; P Lopez-Gonzalez; M P Berges-Gimeno
Journal:  Allergy       Date:  2015-04-24       Impact factor: 13.146

5.  Clinical features of hypersensitivity reactions to carboplatin.

Authors:  M Markman; A Kennedy; K Webster; P Elson; G Peterson; B Kulp; J Belinson
Journal:  J Clin Oncol       Date:  1999-04       Impact factor: 44.544

6.  Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity.

Authors:  Maurie Markman; Kristine Zanotti; Gertrude Peterson; Barbara Kulp; Kenneth Webster; Jerome Belinson
Journal:  J Clin Oncol       Date:  2003-12-15       Impact factor: 44.544

7.  Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience.

Authors:  Aristides Polyzos; Nikolas Tsavaris; Hellen Gogas; John Souglakos; Lambros Vambakas; Nikolaos Vardakas; Kostas Polyzos; Christos Tsigris; Demetrios Mantas; Antonios Papachristodoulou; Nikolas Nikiteas; John G Karavokyros; Evangelos Felekouras; John Griniatsos; Athanasios Giannopoulos; Gregory Kouraklis
Journal:  Oncology       Date:  2008-11-26       Impact factor: 2.935

8.  Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment.

Authors:  R Madrigal-Burgaleta; M P Berges-Gimeno; D Angel-Pereira; R Ferreiro-Monteagudo; C Guillen-Ponce; C Pueyo; E Gomez de Salazar; E Alvarez-Cuesta
Journal:  Allergy       Date:  2013-05-06       Impact factor: 13.146

9.  Advanced (>second) line chemotherapy in the treatment of patients with recurrent epithelial ovarian cancer.

Authors:  Ilan Bruchim; Osnat Jarchowsky-Dolberg; Ami Fishman
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2012-10-22       Impact factor: 2.435
  9 in total
  2 in total

1.  Platin risk stratification algorithm with modified intradermal skin test protocol.

Authors:  Amy S Levin; Benjamin Slawski; Carlos A Camargo; Aleena Banerji
Journal:  J Allergy Clin Immunol Pract       Date:  2019-10-14

2.  Drug Desensitization in the Covid-19 Pandemic Era: Local Success to Widespread Potential.

Authors:  Kimberly G Blumenthal; Mariana Castells; Aleena Banerji
Journal:  Ann Allergy Asthma Immunol       Date:  2021-03-26       Impact factor: 6.347
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.